scispace - formally typeset
Search or ask a question
Institution

Applied Biosystems

About: Applied Biosystems is a based out in . It is known for research contribution in the topics: Mass spectrometry & Nucleic acid. The organization has 1521 authors who have published 1579 publications receiving 285423 citations.


Papers
More filters
Journal ArticleDOI
TL;DR: It is reported here that the abundance of serum- and glucocorticoid-inducible kinase (SGK) is increased in spinal cord tissue from animals reared in microgravity in comparison with 1G-reared controls.
Abstract: The interaction of an animal with its environment during a critical period in early postnatal life has lifelong effects on the structure and function of sensory and motor systems. To gain insight into the molecular mechanisms of experience-dependent development, we challenged young rats to adapt to a new environment that engenders novel motor behavior. Rats born in the gravitational field (1G) of the earth subsequently were reared for 2 weeks either in the absence of gravity (microgravity) or at 1G. A comparison of gene expression using microarrays led to the identification of a panel of differentially regulated transcripts. We report here that the abundance of serum- and glucocorticoid-inducible kinase (SGK) is increased in spinal cord tissue from animals reared in microgravity in comparison with 1G-reared controls. The induction of SGK expression also can be achieved by administration of glucocorticoids to animals at 1G or neurons in vitro. Expression of constitutively active SGK in neurons leads to the elaboration of neuronal dendrites and their branching. Glucocorticoids also lead to dendrite elaboration, and this effect can be abrogated by inhibiting SGK activity. Changes in the level of expression of SGK could be part of the mechanism for experience-dependent acquisition of mature neuronal properties.

25 citations

Patent
07 Feb 2001
TL;DR: In this paper, a G-protein coupled receptor (GPCR) signal activation was detected by employing a GPCR fusion protein comprising an inactive form of an enzyme and an interacting protein partner fusion protein.
Abstract: Methods of detecting G-protein coupled receptor (GPCR) signal activation by employing a GPCR fusion protein comprising an inactive form of an enzyme and an interacting protein partner fusion protein comprising a complementary inactive form of the enzyme contained in the GPCR fusion protein. When the GPCR fusion protein and the protein partner fusion protein bind to one another the two forms of the inactive enzyme associate and produce an active heterodimeric enzyme which is active, permitting detection of the interaction of the GPCR fusion protein with the interacting protein partner fusion protein by measuring the enzyme activity.

25 citations

Journal ArticleDOI
TL;DR: Results of the regression analysis indicate that four highly significant factors that determine average power to detect association are: disease model, average marker-marker disequilibrium, haplotype diversity, and the trait allele frequency.
Abstract: Power and sample size calculations are critical parts of any research design for genetic association. We present a method that utilizes haplotype frequency information and average marker-marker linkag

25 citations

Journal ArticleDOI
TL;DR: In this article, a method for the determination of chloramphenicol (CAP) antibiotic in milk, powder milk and honey was presented, where solid phase extraction and liquid-liquid extraction were applied as clean-up and pre-concentration strategies followed by LC-ESI/MS/MS analysis.
Abstract: The present work shows a method for the determination of chloramphenicol (CAP) antibiotic in milk, powder milk and honey. The solid phase extraction and liquid-liquid extraction were applied as a clean-up and pre-concentration strategies followed by LC-ESI/MS/MS analysis. The recovery was studied for different fortification levels from 0.05 to 1.00 µg L-1 in milk, showing values between 91 101% and RSD bellow 8.0%, while honey was spiked with a concentration of 0.20 µg kg-1 yelding a mean recovery of 83% and RSD of 6.5%. The quantification transition 321>152 showed a LOD of 0.52 ng kg-1 and LOQ of 1.85 ng kg-1.

25 citations

Journal ArticleDOI
U Schobel, I. Coille1, Andreas Brecht1, G M Steinwand1, G Gauglitz1 
TL;DR: The miniaturization of a homogeneous competitive immunoassay to a final assay volume of 70 nL is described, and an antibody-based assay for the detection of the environmentally relevant compound, simazine, in drinking water was chosen.
Abstract: The miniaturization of a homogeneous competitive immunoassay to a final assay volume of 70 nL is described. As the sample carrier, disposable plastic nanotiter plates (NTP) with dimensions of 2 x 2 cm2 containing 25 x 25 wells, corresponding to approximately 15,000 wells on a traditional 96-well microtiter plate footprint, were used. Sample handling was accomplished by a piezoelectrically actuated micropipet. To reduce evaporation while pipetting the assays, the NTP was handled in a closed humid chamber and cooled to the point of condensation. To avoid washing steps, a homogeneous assay was developed that was based on energy-transfer (ET). As a model system, an antibody-based assay for the detection of the environmentally relevant compound, simazine, in drinking water was chosen. Antibodies were labeled with the long-wavelength-excitable sulfoindocyanine dye Cy5 (donor), and a tracer was synthesized by labeling BSA with a triazine derivative and the acceptor dye Cy5.5. At low analyte concentrations, the tracer was preferably bound to the antibody binding sites. As a result of the close proximity of Cy5.5 and Cy5, an efficient quenching of the Cy5 fluorescence occurred. Higher analyte concentrations led to a progressive binding of the analyte to the antibody binding sites. The increased Cy5 fluorescence was determined by using a scanning laser-induced fluorescence detector. The limit of detection (LOD), using an antibody concentration of 20 nM, was 0.32 microg/L, or 1.11 x 10(-16) mol of simazine. In comparison, the LOD of the 96-well microtiter-plate-based ET immunoassay (micro-ETIA) was 0.15 microg/L, or 1.87 x 10(-13) mol. The LOD of the optimized micro-ETIA at 1 nM IgG, was 0.01 microg/L.

25 citations


Authors

Showing all 1521 results

NameH-indexPapersCitations
Richard A. Gibbs172889249708
Friedrich C. Luft113109547619
Alexander N. Glazer7120821068
Vineet Bafna6823642574
Kevin R. Coombes6330823592
Darryl J. Pappin6117029409
Mark D. Johnson6028916103
György Marko-Varga5640912600
Paul Thomas5612844810
Gerald Zon5525611126
Michael W. Hunkapiller5113029756
Bjarni V. Halldorsson5114513180
David H. Hawke501579824
Ellson Y. Chen507128836
Sridhar Hannenhalli4916221959
Network Information
Related Institutions (5)
Genentech
17.1K papers, 1.4M citations

88% related

National Institutes of Health
297.8K papers, 21.3M citations

86% related

Scripps Research Institute
32.8K papers, 2.9M citations

86% related

Hoffmann-La Roche
43K papers, 1.6M citations

85% related

Wellcome Trust Sanger Institute
9.6K papers, 1.2M citations

85% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20182
20171
20164
20152
20147
201313